Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2026-01-06 @ 4:34 AM
Study NCT ID:
NCT04632459
Status:
UNKNOWN
Last Update Posted:
2022-03-11
First Post:
2020-09-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-12-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-09-04
First Submit QC Date:
None
Study First Post Date:
2020-11-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-23
Last Update Post Date:
2022-03-11
Last Update Post Date Type:
ACTUAL